Press release – For immediate release – 5:45 pm CET
Median Technologies to speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA
- AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD”
- Median’s teams will be at booth #4465, South Hall Level 3, to present the latest developments on iBiopsy® as well as the imaging CRO offering.
Median Technologies (ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the Radiological Society of North America (RSNA) 2023 Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 26-30, 2023.
The Company will give a presentation. Details of the session include:
Session: AI Theater
Presentation: Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD
Date: November 26, 2023 – 1:00 pm – 1:15 pm CT
Place: South Hall Level 3, AI showcase theater
Median’s iBiopsy® and iCRO teams will be available at booth #4465, Level 3 South Hall (AI showcase) for the duration of the industry exhibition (Nov 26- 29, 10:00 am – 5:00 pm CT).
Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median’s offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China is listed on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME).